Condition: Low Back Pain · Vertebrogenic Pain Syndrome · Basivertebral Nerve Ablation · Sponsor: Yale University
Basivertebral nerve ablation (BVNA) is a minimally invasive procedure approved for vertebrogenic low back pain. While early studies support its efficacy, real-world evidence is still evolving, particularly regarding the trajectory of pain relief and functional improvement over time, and predictors of clinical response. This study aims to evaluate clinical outcomes longitudinally following BVNA and identify baseline predictors of response.
This description comes directly from the study's public registry record.
Charles A Odonkor, MD · 203-767-1555 · kcodonkor@aya.yale.edu
Muhammad U Siddique, MD · 203-668-2772 · muhammad.siddique@yale.edu
Always discuss trial participation with your own doctor first.
| Yale Spine and Pain Center - Guilford | Guilford, Connecticut, United States | Recruiting |
| Yale Pain Management Center - New Haven | New Haven, Connecticut, United States | Recruiting |
| Yale Interventional Spine and Musculoskeletal Medicine - Old Saybrook | Old Saybrook, Connecticut, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07433634